Your browser doesn't support javascript.
loading
Skin Cancer Induction by the Antimycotic Drug Voriconazole Is Caused by Impaired DNA Damage Detection Due to Chromatin Compaction.
Giovannini, Sara; Weibel, Lisa; Schittek, Birgit; Sinnberg, Tobias; Schaller, Martin; Lemberg, Christina; Fehrenbacher, Birgit; Biesemeier, Antje; Nordin, Renate; Ivanova, Irina; Kurz, Bernadett; Svilenska, Teodora; Berger, Christoph; Bourquin, Jean-Pierre; Kulik, Andreas; Fassihi, Hiva; Lehmann, Alan; Sarkany, Robert; Kobert, Nikita; van Toorn, Marvin; Marteijn, Jurgen A; French, Lars E; Rocken, Martin; Vermeulen, Wim; Kamenisch, York; Berneburg, Mark.
Afiliación
  • Giovannini S; Department of Dermatology, University Regensburg, Regensburg, Germany; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Weibel L; Department of Pediatric Dermatology and Children's Research Center, University Children's Hospital Zurich, Switzerland.
  • Schittek B; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Sinnberg T; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany; Department of Dermatology, Venereology and Allergology, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Schaller M; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Lemberg C; Section of Immunology, Vetsuisse Faculty, University of Zurich, Zurich, Switzerland.
  • Fehrenbacher B; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Biesemeier A; Division of Experimental Vitreoretinal Surgery and Core Facility for Electron Microscopy, Center for Ophthalmology, Schleichstr, Tuebingen, Germany; MRT - Materials Research and Technology Department, Luxembourg Institute of Science and Technology (LIST), Belvaux, Luxembourg.
  • Nordin R; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Ivanova I; Department of Dermatology, University Regensburg, Regensburg, Germany.
  • Kurz B; Department of Dermatology, University Regensburg, Regensburg, Germany.
  • Svilenska T; Department of Dermatology, University Regensburg, Regensburg, Germany.
  • Berger C; Division of Infectious Diseases and Children's Research Center, University Children's Hospital Zurich, Switzerland.
  • Bourquin JP; Department of Pediatric Oncology and Children's Research Center, University Children's Hospital Zurich, Switzerland.
  • Kulik A; Interfaculty Institute of Microbiology and Infection Medicine, Eberhard Karls University, Tuebingen, Germany.
  • Fassihi H; Guy's and St Thomas' NHS Trust, Guy's Hospital, London, United Kingdom.
  • Lehmann A; Genome Damage and Stability Centre, University of Sussex, Falmer, Brighton, United Kingdom.
  • Sarkany R; Guy's and St Thomas' NHS Trust, Guy's Hospital, London, United Kingdom.
  • Kobert N; ICB Institute for Chemical and Bioengineering, ETH Zurich, Zurich, Switzerland.
  • van Toorn M; Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Marteijn JA; Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
  • French LE; Department of Dermatology and Allergy, University Hospital, Ludwig Maximilan University Munich, Munich, Germany; Dr. Philip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Rocken M; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Vermeulen W; Department of Molecular Genetics, Oncode Institute, Erasmus MC Cancer Institute, Erasmus University Medical Center, Rotterdam, Netherlands.
  • Kamenisch Y; Department of Dermatology, University Regensburg, Regensburg, Germany; Department of Dermatology, Eberhard Karls University, Tuebingen, Germany.
  • Berneburg M; Department of Dermatology, University Regensburg, Regensburg, Germany. Electronic address: mark.berneburg@ukr.de.
J Invest Dermatol ; 144(11): 2465-2476, 2024 Nov.
Article en En | MEDLINE | ID: mdl-39047967
ABSTRACT
Phototoxicity and skin cancer are severe adverse effects of the anti-fungal drug voriconazole (VOR). These adverse effects resemble those seen in xeroderma pigmentosum, caused by defective DNA nucleotide excision repair (NER), and we show that VOR decreases NER capacity. We show that VOR treatment does not perturb the expression of NER, or other DNA damage-related genes, but that VOR localizes to heterochromatin, in complexes containing histone acetyltransferase general control of amino-acid synthesis 5-like 2. Impairment of general control of amino-acid synthesis 5-like 2 binding to histone H3 reduced acetylation of H3, restricting damage-dependent chromatin unfolding, thereby reducing NER initiation. Restoration of H3 histone acetylation using histone deacetylase inhibitors, rescued VOR-induced NER repression, thus offering a preventive therapeutic option. These findings underline the importance of DNA damage-dependent chromatin remodeling as an important prerequisite of functional DNA repair.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Daño del ADN / Histonas / Reparación del ADN / Voriconazol / Antifúngicos Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Alemania

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Daño del ADN / Histonas / Reparación del ADN / Voriconazol / Antifúngicos Límite: Humans Idioma: En Revista: J Invest Dermatol Año: 2024 Tipo del documento: Article País de afiliación: Alemania